NWHN in the News
Women’s health topics attract a lot of media attention – whether it’s new research about menopause, a question about the safety of breast implants or a contraceptive, or a political attack on critical women’s health services. The NWHN is a trusted source for explaining women’s perspectives on these, and many other, health developments. Here are some recent articles that include comments from the NWHN:
The lawsuit to eliminate the medically unjustified age restriction that block women's access to emergency contraception has taken another step forward, and NWHN Program Director Amy Allina commented on it in this Bloomberg News article. (February 2012)
Huffington Post covered students from Catholic colleges speaking out in support of the contraceptive coverage rules and led with NWHN Program Coordinator Keely Monroe's story. (February 2012)
In this Salon article about the Komen Foundation’s decision to cut off grants for breast cancer screening to Planned Parenthood clinics, NWHN ED Cindy Pearson calls Komen out for its cowardice, caving to an anti-choice, anti-women’s health agenda. (February 2012)
NWHN Executive Director Cindy Pearson reacts to the Obama Administration's decision to stand up for women by requiring full insurance coverage for contraception without extra costs in the Wall Street Journal. (January 2012)
In this Bloomberg Businessweek article, Amy Allina calls the FDA's decision to require companies to collect safety data on vaginal mesh a good first step in protecting women from dangerous medical devices. (January 2012)
If you missed the interview Cynthia Pearson gave on BioCentury, click here to see her discuss the public health consequences of the Secretary’s unprecedented decision to overrule the FDA’s decision to allow emergency contraception without age restrictions. (January 2012)
National Women’s Health Network and its women’s health allies are also mentioned in this Huffington Post article about Secretary Sebilius overruling the FDA decision on removing age restrictions on emergency contraception. (December 2011)
Read Executive Director Cynthia Pearson in this Reuter’s article criticizing the FDA advisory committee’s decision to recommend that Bayer pharmaceuticals change their label to reflect the possible dangers of Yaz and Yasmin, drosperinone-containing oral contraceptives. (December 2011)
AlertNet, a humanitarian news site, quoted Amy Allina about the concerning lack of long-term study data about cosmetic breast implant rupture and cancer incidence rates. (December 2011)
